Clinical Trial Update: An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 extension study assessing long-term safety and tolerability of degarelix in Chinese patients with prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• degarelix (degarelix)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED